Editas Medicine

-$2.17 (-5.05%) Today
$0.00 (0.00%) As of 9:06 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).

CEO
James C. Mullen
Employees
235
Headquarters
Cambridge, Massachusetts
Founded
2013

EDIT Key Statistics

Market Cap
2.77B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.44M
High Today
$42.63
Low Today
$40.21
Open Price
$42.47
Volume
1.02M
52 Week High
$99.95
52 Week Low
$27.01

EDIT News

Benzinga4h

Analyzing Editas Medicine's Unusual Options Activity

On Friday, shares of Editas Medicine (NASDAQ:EDIT) saw unusual options activity. After the option alert, the stock price moved down to $40.88. Sentiment: BULLI
Simply Wall StJul 18

Do Institutions Own Editas Medicine, Inc. Shares?

The big shareholder groups in Editas Medicine, Inc. (NASDAQ:EDIT) have power over the company. Generally speaking, as a company grows, institutions will increas

EDIT Earnings

-$1.00
-$0.63
-$0.25
$0.12
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure